Lecap Asset Management Ltd. Invests $760,000 in Waters Corporation $WAT

Key Points

• Lecap Asset Management Ltd. has made a new investment of $760,000 in Waters Corporation, acquiring 2,177 shares during the 2nd quarter.
• Waters Corporation reported earnings of $2.95 per share for the last quarter, beating analysts' expectations and showing an 8.8% increase in revenue year-over-year.
• The stock currently holds a consensus rating of "Moderate Buy" with a target price averaging $380.43 as assessed by various analysts.

Lecap Asset Management Ltd. purchased a new stake in shares of Waters Corporation (NYSE:WAT - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 2,177 shares of the medical instruments supplier's stock, valued at approximately $760,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Robeco Institutional Asset Management B.V. lifted its holdings in shares of Waters by 16.3% in the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 515,495 shares of the medical instruments supplier's stock worth $179,928,000 after acquiring an additional 72,174 shares during the last quarter. PFG Investments LLC boosted its position in shares of Waters by 4.4% during the second quarter. PFG Investments LLC now owns 1,433 shares of the medical instruments supplier's stock valued at $500,000 after buying an additional 60 shares during the period. Truist Financial Corp grew its stake in shares of Waters by 8.7% during the second quarter. Truist Financial Corp now owns 6,340 shares of the medical instruments supplier's stock valued at $2,213,000 after buying an additional 509 shares during the last quarter. Janney Montgomery Scott LLC raised its holdings in shares of Waters by 1.7% in the second quarter. Janney Montgomery Scott LLC now owns 4,896 shares of the medical instruments supplier's stock worth $1,709,000 after buying an additional 83 shares during the period. Finally, V Square Quantitative Management LLC lifted its stake in shares of Waters by 5.3% during the 2nd quarter. V Square Quantitative Management LLC now owns 1,752 shares of the medical instruments supplier's stock worth $612,000 after acquiring an additional 88 shares during the last quarter. 94.01% of the stock is owned by hedge funds and other institutional investors.

Waters Price Performance

WAT opened at $321.60 on Friday. The firm has a market capitalization of $19.14 billion, a PE ratio of 29.00, a price-to-earnings-growth ratio of 2.98 and a beta of 1.04. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22. The business's 50-day moving average is $296.39 and its two-hundred day moving average is $325.96. Waters Corporation has a 1 year low of $275.05 and a 1 year high of $423.56.

Waters (NYSE:WAT - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share for the quarter, beating analysts' consensus estimates of $2.93 by $0.02. Waters had a net margin of 21.71% and a return on equity of 38.60%. The business had revenue of $771.33 million for the quarter, compared to analysts' expectations of $745.96 million. During the same period last year, the business earned $2.63 EPS. The company's revenue was up 8.8% compared to the same quarter last year. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Research analysts anticipate that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on WAT shares. Wall Street Zen lowered Waters from a "buy" rating to a "hold" rating in a research note on Saturday, July 26th. UBS Group reaffirmed a "neutral" rating on shares of Waters in a research report on Tuesday, July 15th. Jefferies Financial Group set a $385.00 price target on Waters and gave the company a "buy" rating in a report on Monday, August 4th. Scotiabank restated a "sector outperform" rating and set a $465.00 price objective on shares of Waters in a report on Friday, July 11th. Finally, Wells Fargo & Company lowered their target price on Waters from $330.00 to $315.00 and set an "equal weight" rating for the company in a report on Tuesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $380.43.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.